These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16901558)

  • 1. Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination.
    Maier AG; Braks JA; Waters AP; Cowman AF
    Mol Biochem Parasitol; 2006 Nov; 150(1):118-21. PubMed ID: 16901558
    [No Abstract]   [Full Text] [Related]  

  • 2. Negative selection of Plasmodium falciparum reveals targeted gene deletion by double crossover recombination.
    Duraisingh MT; Triglia T; Cowman AF
    Int J Parasitol; 2002 Jan; 32(1):81-9. PubMed ID: 11796125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Killing effect of adenovirus mediated fusion gene cytosine and deaminase uracil phosphoribosyl transferase directed by glutathione S-transferase P1 promoter on cisplatin-resistant ovarian cancer cells in vitro].
    Cai LQ; Li M; Lu S; Wang HB; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):478-81. PubMed ID: 15347473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bystander effect from cytosine deaminase and uracil phosphoribosyl transferase genes in vitro: a partial contribution of gap junctions.
    Tanaka T; Duflot-Dancer A; Tiraby M; Piccoli C; Tiraby G; Yamasaki H; Mesnil M
    Cancer Lett; 2009 Sep; 282(1):43-7. PubMed ID: 19342154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved negative selection protocol for Plasmodium berghei in the rodent malarial model.
    Orr RY; Philip N; Waters AP
    Malar J; 2012 Mar; 11():103. PubMed ID: 22463060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and application of a positive-negative selectable marker system for use in reverse genetics in Plasmodium.
    Braks JA; Franke-Fayard B; Kroeze H; Janse CJ; Waters AP
    Nucleic Acids Res; 2006 Mar; 34(5):e39. PubMed ID: 16537837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified vaccinia virus Ankara as a vector for suicide gene therapy.
    Erbs P; Findeli A; Kintz J; Cordier P; Hoffmann C; Geist M; Balloul JM
    Cancer Gene Ther; 2008 Jan; 15(1):18-28. PubMed ID: 17992203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capturing in vivo RNA transcriptional dynamics from the malaria parasite
    Painter HJ; Carrasquilla M; Llinás M
    Genome Res; 2017 Jun; 27(6):1074-1086. PubMed ID: 28416533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast dihydroorotate dehydrogenase as a new selectable marker for Plasmodium falciparum transfection.
    Ganesan SM; Morrisey JM; Ke H; Painter HJ; Laroiya K; Phillips MA; Rathod PK; Mather MW; Vaidya AB
    Mol Biochem Parasitol; 2011 May; 177(1):29-34. PubMed ID: 21251930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine deaminase MX cassettes as positive/negative selectable markers in Saccharomyces cerevisiae.
    Hartzog PE; Nicholson BP; McCusker JH
    Yeast; 2005 Jul; 22(10):789-98. PubMed ID: 16088873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Therapeutic Gene FCU1 Sensitizes Pancreatic Cancer Cells to 5-Fluorocytosine and Enhances the Cytotoxic Effect of 5-Fluorouracil.
    Kopantsev EP; Kostina MB; Grankina EV; Kopantseva MR; Egorov VI; Sverdlov ED
    Bull Exp Biol Med; 2016 Oct; 161(6):808-810. PubMed ID: 27783293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a negative selectable marker for Entamoeba histolytica.
    Abhyankar MM; Haviland SM; Gilchrist CA; Petri WA
    J Vis Exp; 2010 Dec; (46):. PubMed ID: 21189470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evidence for Plasmodium falciparum resistance to chloroquine and pyrimethamine in Indochina and the Western Pacific between 1984 and 1998.
    Saito-Nakano Y; Tanabe K; Kamei K; Iwagami M; Komaki-Yasuda K; Kawazu S; Kano S; Ohmae H; Endo T
    Am J Trop Med Hyg; 2008 Oct; 79(4):613-9. PubMed ID: 18840753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic prerequisites for additive or synergistic actions of 5-fluorocytosine and fluconazole in baker's yeast.
    Paluszynski JP; Klassen R; Meinhardt F
    Microbiology (Reading); 2008 Oct; 154(Pt 10):3154-3164. PubMed ID: 18832321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in pfcrt, pfmdr1, dhfr genes and in vitro responses to antimalarials in Plasmodium falciparum isolates from Bangui, Central African Republic.
    Menard D; Yapou F; Manirakiza A; Djalle D; Matsika-Claquin MD; Talarmin A
    Am J Trop Med Hyg; 2006 Sep; 75(3):381-7. PubMed ID: 16968910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of a suicide gene to human colorectal tumors by a conditionally replicating vaccinia virus.
    Foloppe J; Kintz J; Futin N; Findeli A; Cordier P; Schlesinger Y; Hoffmann C; Tosch C; Balloul JM; Erbs P
    Gene Ther; 2008 Oct; 15(20):1361-71. PubMed ID: 18480846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance-mediating polymorphisms in Plasmodium falciparum infections in Kinshasa, Democratic Republic of the Congo.
    Mobula L; Lilley B; Tshefu AK; Rosenthal PJ
    Am J Trop Med Hyg; 2009 Apr; 80(4):555-8. PubMed ID: 19346374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism of flucytosine resistance in Candida lusitaniae: contribution of the FCY2, FCY1, and FUR1 genes to 5-fluorouracil and fluconazole cross-resistance.
    Papon N; Noël T; Florent M; Gibot-Leclerc S; Jean D; Chastin C; Villard J; Chapeland-Leclerc F
    Antimicrob Agents Chemother; 2007 Jan; 51(1):369-71. PubMed ID: 17060521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.